ArticleDermatology practical & conceptual2022

Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome.

Irene Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.